Language selection

Government of Canada / Gouvernement du Canada

Search

Recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants.: HP40-308/2022E-1-PDF

"The objective of this advisory committee statement is to review evidence and develop guidance on strategies to prevent severe consequences of RSV infection in children at high risk of severe RSV disease by administration of monoclonal antibody"--Guidance objective, page 8.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.913694&sl=0

Publication information
Department/Agency
  • Canada. National Advisory Committee on Immunization, issuing body.
TitleRecommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants.
Publication typeMonograph
Language[English]
Other language editions[French]
Earlier editionRecommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants.
FormatDigital text
Electronic document
Note(s)
  • Cover title.
  • "Publication date: June 2022."
  • Publication copy replaced 2022-12-12 at request of authors.
  • At head of title: An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI).
  • Issued also in French under title: Utilisation recommandée du palivizumab pour réduire les complications de l'infection par le virus respiratoire syncytial chez les nourrissons.
  • Includes bibliographical references (pages 76-97).
Publishing information
  • [Ottawa] : Public Health Agency of Canada = Agence de la santé publique du Canada, 2022.
  • ©2022
Description1 online resource (151 pages)
ISBN9780660447117
Catalogue number
  • HP40-308/2022E-1-PDF
Departmental catalogue number220345
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details

Report a problem or mistake on this page
Date modified: